Effects of cessation of immunosuppression on skeleton reconstructed by vascularized bone allograft in rats

Journal of Orthopaedic Research

Volumn 22, Issue 2, 2004, Pages 388-394

  Ikeda, Keisuke ^a   Shigetomi, Mitsunori ^a   Ihara, Koichiro ^a   Tsubone, Tetsu ^a   Hashimoto, Takahiro ^a   Kawano, Hiroo ^a   Sugiyama, Toshihiro ^a   Kawai, Shinya ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Blood supply; Electrical stimulation; Fracture healing

Indexed keywords

CYCLOSPORIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ALLOGRAFT; BONE BLOOD FLOW; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE STRUCTURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DONOR; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECIPIENT;

ANIMALS; BONE DENSITY; BONE TRANSPLANTATION; CYCLOSPORINE; DENSITOMETRY, X-RAY; FIBULA; GRAFT SURVIVAL; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, INBRED LEW; RECOVERY OF FUNCTION; TIBIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0742319020     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00182-7     Document Type: Article

References (25)

1. Buchinsky F.J. Ma Y. Mann G.N. et al. T lymphocytes play a critical role in the development of cyclosporine A-induced osteopenia Endocrinology 137 1996 2278-2285
2. Burchardt H. Glowczewskie F.P. Enneking W.F. Short-term immunosuppression with fresh segmental fibular allografts in dogs J. Bone Joint Surg. Am. 63A 1981 411-415
3. Dell P.C. Burchardt H. Glowczewskie Jr. F.P. A roentgenographic, biomechanical, and histological evaluation of vascularized and non-vascularized segmental fibular canine autografts J. Bone Joint Surg. Am. 67A 1985 105-112
4. Delmas P.D. Osteoporosis in patients with organ transplants: a neglected problem Lancet 357 2001 325-326
5. Deluca H.F. Cantorna M.T. Vitamin D: its role and uses in immunology FASEB J. 15 2001 2579-2585
6. Doi K. Akino T. Shigetomi M. et al. Vascularized bone allografts: review of current concepts Microsurgery 15 1994 831-841
7. Doi K. Kawai S. Shigetomi M. Congenital tibial pseudoarthrosis treated with vascularized bone allograft Lancet 347 1996 970-971
8. Doi K. Akino T. Shigetomi M. et al. Revascularized intercalary bone allografts with short-term immunosuppression with cyclosporine in the canine Plast. Reconstr. Surg. 101 1998 793-801
9. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton J. Bone Miner. Res. 11 1996 1-7
10. Epstein S. Dissanayake R. Goodman G.R. et al. Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat Calcif. Tissue Int. 68 2001 240-247
11. Goodman G.R. Dissanayake I.R. Bowman A.R. et al. Transforming growth factor-β administration modifies cyclosporine A-induced bone loss Bone 28 2001 583-588
12. Hamano K. Ohmi M. Esato K. Fukumoto T. Effect of donor specific transfusion (DST) is restricted to the rat combination used and closely related with alloantibody in heart transplantation Immunol. Cell Biol. 67 1989 297-302
13. Hoffmann G.O. Kirschner M.H. Wagner F.D. et al. Allogenic vascularized transplantation of human femoral diaphyses and total knee joints: first clinical experiences Transplant. Proc. 30 1998 2754-2761
14. Hoffmann G.O. Kirschner M.H. Clinical experience in allogenic vascularized bone and joint allografting Microsurgery 20 2000 375-383
15. Leidig-Bruckner G. Hosch S. Dodidou P. et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study Lancet 357 2001 342-347
16. 3, on bone reconstruction by vascularized bone allograft Bone 30 2002 422-427
17. Movsowitz C. Epstein S. Fallon M. et al. Cyclosporine-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration Endocrinology 123 1988 2571-2577
18. Muramatsu K. Bishop A.T. Cell repopulation in vascularized bone grafts J. Orthop. Res. 20 2002 772-778
19. Ohno T. Shigetomi M. Ihara K. et al. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A Calcif. Tissue Int. 72 2003 50-56
20. Ramsey-Goldman R. Dunn J.E. Dunlop D.D. et al. Increased risk of fracture in patients receiving solid organ transplants J. Bone Miner. Res. 14 1999 456-463
21. Rodino M.A. Shane E. Osteoporosis after organ transplantation Am. J. Med. 104 1998 459-469
22. Schlosberg M. Movsowitz C. Epstein S. et al. The effect of cyclosporine A administration and its withdrawal on bone mineral metabolism in the rat Endocrinology 124 1989 2179-2184
23. Shigetomi M. Doi K. Kuwata N. et al. Experimental study on vascularized bone allografts for reconstruction of massive bone defects Microsurgery 15 1994 663-670
24. Shigetomi M. Hickey M.J. Hurley J.V. et al. Orthotopic vascularized osteochondral allografts in an immunosuppressed rat model J. Reconstr. Microsurg. 12 1996 113-119
25. Sodam B.R. Awumey E.M.K. Sampson W.H. Epstein S. The endothelin receptor antagonist, L-754, 142 does not prevent cyclosporine A-induced osteopenia in rats Calcif. Tissue Int. 68 2001 117-121